Conference abstract · 7 Mar 2016
Conference abstractPublished 17 Aug 2015
Non-ionic Surfactant Vesicles as Delivery System for Letrozole
Qatar University, Qatar
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aromatase is an enzyme that leads the bioconversion of androgen into estrogen, which is a main source for cell proliferation and growth in hormone dependent breast cancer. Letrozole (LTZ) is a third generation potent aromatase inhibitor that is approved by the Food and Drug Administration (FDA) for the management of hormone positive breast cancer. The current formulation (Femara®) lacks an effective bioavailability due to LTZ poor-water solubility and rapid systemic metabolism.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 25 Sep 2024
Advancements in Doxorubicin Delivery Systems: The Role of Non-Ionic Surfactant Vesicles (Niosomes)
Conference abstract · 27 Jan 2020
Formulation of non-ionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells
Conference abstract · 2020
Nano Mat 2020: Formulation of non-ionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells- Mohammad Ali Obeid- Yarmouk University, Irbid-Jordan
Conference abstract · 18 Jul 2019
Formulation of non-ionic surfactant vesicles prepared by microfluidics for therapeutic delivery of siRNA into cancer cells
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Nada Khudair”
